PolymarketVerifica disponibilitàSenza KYC2% di commissioneDati di risoluzione verificatiDiscretamente calibrato
Probabilità implicita attuale
December 31, 68%+1.0pt
Qualita del mercato
67 / 100
Qualità media
Volume 24h
1,9K €
Liquidità
16,9K €
Liquidità media
Bid / Ask
67.0% / 68.0%
Spread
1.0 pt
Spread stretto
Comments
0
Dati di mercato
Aggiornato 15 minuti fa
19 ago 26, 17:4931 dic 27, 23:59
Trend
Esito24hProbabilità
Regole
This market will resolve to "Yes" if the U.S. Food and Drug Administration (FDA) grants approval of intismeran autogene for any indication by December 31, 2027, 11:59 PM ET.
Otherwise, this market will resolve to "No".
Intismeran autogene refers to the individualized neoantigen therapy developed by Moderna and Merck and evaluated in the Phase 3 INTerpath-001 trial (NCT05933577), also known as mRNA-4157 and V940, together with any brand, trade, or nonproprietary name later assigned to that product, as well as any renamed or modified version that the relevant company or the FDA identify as the same product or a direct continuation of the V940/mRNA-4157 program.
Differences in neoantigen composition between patients will not affect resolution.
Changes to the product's formulation will not affect resolution, provided the FDA approves the product described above.
Approval as part of a combination regimen will qualify.
Quali sono le probabilità attuali per FDA approves skin cancer vaccine by which date??
Polymarket quota December 31, al 68% al 21 agosto 2026.
Quando si risolve FDA approves skin cancer vaccine by which date??
FDA approves skin cancer vaccine by which date? dovrebbe risolversi il 31 dicembre 2027.
Come viene liquidato FDA approves skin cancer vaccine by which date??
Polymarket liquida questo mercato come segue: This market will resolve to "Yes" if the U.S. Food and Drug Administration (FDA) grants approval of intismeran autogene for any indication by December 31, 2027, 11:59 PM ET.